Company record · updated August 5, 2026
Aura Biosciences, Inc.: 11 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs October 8, 2021 to October 8, 2021.
11observations
1source filings
11verified rows
2021-10-08most recent as-of date
Source rails for this company: S-1 charter round (11).
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2021-10-08 | Series E price per share | 0.7839 USD | — | VERIFIED | "Original Issue Price" defined for Series E | 000119312521295543 |
| 2021-10-08 | Series D-2 price per share | 0.6911 USD | — | VERIFIED | "Original Issue Price" defined for Series D-2 | 000119312521295543 |
| 2021-10-08 | Series D-1 price per share | 0.6911 USD | — | VERIFIED | "Original Issue Price" defined for Series D-1 | 000119312521295543 |
| 2021-10-08 | Series D price per share | 0.6911 USD | — | VERIFIED | "Original Issue Price" defined for Series D | 000119312521295543 |
| 2021-10-08 | Series C-2 price per share | 0.3649 USD | — | VERIFIED | "Original Issue Price" defined for Series C-2 | 000119312521295543 |
| 2021-10-08 | Series C-1 price per share | 0.3649 USD | — | VERIFIED | "Original Issue Price" defined for Series C-1 | 000119312521295543 |
| 2021-10-08 | Series C price per share | 0.5213 USD | — | VERIFIED | "Original Issue Price" defined for Series C | 000119312521295543 |
| 2021-10-08 | Series B price per share | 1.2424 USD | — | VERIFIED | "Original Issue Price" defined for Series B | 000119312521295543 |
| 2021-10-08 | Series A-2 price per share | 1.2424 USD | — | VERIFIED | "Original Issue Price" defined for Series A-2 | 000119312521295543 |
| 2021-10-08 | Series A-1 price per share | 1.2424 USD | — | VERIFIED | "Original Issue Price" defined for Series A-1 | 000119312521295543 |
| 2021-10-08 | Series A price per share | 2.4847 USD | — | VERIFIED | "Original Issue Price" defined for Series A | 000119312521295543 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.